BioPharma Dive – AI / Data
RA Capital targets China with latest SPAC deal
The prominent investor aims to merge its latest special purpose acquisition company with a Chinese biotech, according to a securities filing.
The prominent investor aims to merge its latest special purpose acquisition company with a Chinese biotech, according to a securities filing.